Figure 4From: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts Proliferation rate of MSC exposed to dasatinib alone or in combination with DAG. A: Cells were treated for 3, 7 and 10 days with increasing concentrations of the drug (10-9 - 10-4 M) or vehicle (Control) in complete culture medium. B: Cells were exposed to increasing concentrations of the dasatinib (10-9 - 10-4 M) or vehicle (Control) in complete culture medium supplemented or not with DAG for 3, 7 and 10 days. A, B: Cell proliferation was determined by a colorimetric assay using the Cell Proliferation Reagent WST-1. The results are presented as mean ± SEM from 4 independent experiments performed in duplicate; * p < 0.05 versus the corresponding control.Back to article page